Journal Mobile Options
Table of Contents
Vol. 1, No. 4, 1995
Issue release date: 1995
Section title: Special Topic Section: Personality Disorders and Addiction
Eur Addict Res 1995;1:166–177
(DOI:10.1159/000259080)

Prevalence of Personality Disorders among Alcoholics and Drug Addicts: An Overview

Verheul R. · van den Brink W. · Hartgers C.
Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Special Topic Section: Personality Disorders and Addiction

Published online: 11/11/2009

Number of Print Pages: 12
Number of Figures: 0
Number of Tables: 0

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: http://www.karger.com/EAR

Abstract

Personality disorders (PDs) are considered to be potential predictors of outcome and potential matching variables. In this report the authors review the available epidemiological studies regarding the overall prevalence of DSM-III(Pv) PDs in alcohol, cocaine, opiate and polydrug addicts in both patient and nonpatient samples. Special attention is paid to the prevalence of antisocial and borderline PDs. Fifty-two studies were identified covering the time period 1982–1994. The findings of these studies suggest that the best estimate of overall axis II prevalence ranges from 44% among alcoholics to 79% among opiate addicts. However, a wide range of prevalence rates was observed in all types of substance use disorders. These differences could only partly be accounted for by differences in primary substance of abuse, assessment procedure, and setting. Gender distribution, the alternate application of exclusion criteria, classification system and time-frame, seem to be other important factors in understanding the divergent findings.


  

Author Contacts

Roel Verheul, MA, Amsterdam Institute for Addiction Research, Jacob Obrechtstraat 92, NL-1071 KR Amsterdam (The Netherlands)

  

Article Information

Published online: November 11, 2009
Number of Print Pages : 12

  

Publication Details

European Addiction Research

Vol. 1, No. 4, Year 1995 (Cover Date: 1995)

Journal Editor: van den Brink W. (Amsterdam), Haasen C. (Hamburg)
ISSN: 1022-6877 (Print), eISSN: 1421-9891 (Online)

For additional information: http://www.karger.com/EAR


Article / Publication Details

First-Page Preview
Abstract of Special Topic Section: Personality Disorders and Addiction

Published online: 11/11/2009

Number of Print Pages: 12
Number of Figures: 0
Number of Tables: 0

ISSN: 1022-6877 (Print)
eISSN: 1421-9891 (Online)

For additional information: http://www.karger.com/EAR


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.